IL6 and neoplasm: Tumor-derived IL-6 stimulates the STAT3 pathway in CAFs (Karakasheva et al., 2018), sustaining the CSC-like characteristics of tumor cells by prompting CAFs to release MMPs (Liao et al., 2017).